The Journal of Infectious Diseases · 2015 · 145 citations · 30 references
Life SciencesGeneticsNeuroscienceComparative GenomicsMicrobial GeneticsNeuroimmunologyBacterial ToxinsBotulinum Toxin TherapyToxin ProductionToxin-mediated DiseaseToxin-mediated PathogenesisAntitoxin TherapyBacterial NeurotoxinsBotulinum NeurotoxinBotulinum ToxinsComparative Toxin GenomicsToxin GenesToxin-antitoxin SystemsToxin-encoding Genes
Botulism is a potentially fatal paralytic disease caused by the action of botulinum neurotoxin (BoNT) on nerve cells. There are 7 known serotypes (A-G) of BoNT and up to 40 genetic variants. Clostridium botulinum strain IBCA10-7060 was recently reported to produce BoNT serotype B (BoNT/B) and a novel BoNT, designated as BoNT/H. The BoNT gene (bont) sequence of BoNT/H was compared to known bont sequences. Genetic analysis suggested that BoNT/H has a hybrid-like structure containing regions of similarity to the structures of BoNT/A1 and BoNT/F5. This novel BoNT was serologically characterized by the mouse neutralization assay and a neuronal cell-based assay. The toxic effects of this hybrid-like BoNT were completely eliminated by existing serotype A antitoxins, including those contained in multivalent therapeutic antitoxin products that are the mainstay of human botulism treatment.
30
Kavita S. Lole, Robert C. Bollinger, Ramesh Paranjape et al. · Journal of Virology · 1999 · 2.8K citations · Full text
Human Botulism Immune Globulin for the Treatment of Infant Botulism
Stephen S. Arnon, Robert Schechter, Susan E. Maslanka et al. · New England Journal of Medicine · 2006 · 499 citations · Full text
Genetic Diversity among Botulinum Neurotoxin-Producing Clostridial Strains
Kelly Hill, Theresa J. Smith, Charles H. Helma et al. · Journal of Bacteriology · 2006 · 380 citations · Full text